Skip to content
2000
Volume 33, Issue 5
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Introduction

Several pathological conditions, including glaucoma, malignant brain tumors, and renal, gastric, and pancreatic carcinomas, are commonly associated with carbonic anhydrase type II (CA-II). Additionally, CA-II plays a critical role in regulating bicarbonate concentration in the eyes. The inhibition of CA-II reduces aqueous humor production and thus lowers intraocular pressure associated with glaucoma.

Objectives

This study aimed to synthesize potent CA-II inhibitors, 5-nitro-1H-benzo[d]imidazole-2(3H)-thione (5NBIT) and acylhydrazone derivatives (-).

Methods

In this study, a new series of potent CA-II inhibitors, (5NBIT) and acylhydrazone derivatives (), were synthesized and characterized by IR, NMR, UV and mass spectroscopy and evaluated against bovine carbonic anhydrase-II (CA-II).

Results

Interestingly, most of the compounds showed better inhibition than the standard drug, acetazolamide (IC: 18.2±0.51 µM), such as compounds (IC: 10.5±0.81 µM), (IC: 11.3±0.36 µM), (IC: 16.5±0.53 µM), (IC: 15.8±1.02 µM), (IC: 13.7±1.03 µM), and (IC: 12.2±1.03 µM). Among the synthesized compounds, compound (IC: 8.2±0.32 µM) exhibited the highest and compound (IC: 27.6±0.39 µM) showed the lowest inhibition. Structure-activity relationships suggest that the presence of nitro group on the phenyl ring contributed significantly to the overall inhibitory activity. Molecular docking of all the active compounds was performed to predict their binding behavior, which indicated good agreement between docking and experimental findings. Moreover, the MD simulation of compound also showed excellent binding behavior and binding energy within the binding cavity of CA-II.

Conclusion

These findings suggest that the synthesized 5NBIT and acylhydrazone derivatives exhibited potent CA-II inhibition, with several compounds outperforming the standard drug acetazolamide. These results provide valuable insights for the development of novel CA-II inhibitors with potential therapeutic applications in glaucoma and other related conditions.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673365555250617114928
2025-10-06
2026-02-24

  • From This Site

    /content/journals/cmc/10.2174/0109298673365555250617114928
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Hewett-EmmettD. Evolution and distribution of the carbonic anhydrase gene families.EXS.2000902976
     [Google Scholar]
  2. JakubowskiM. Szahidewicz-KrupskaE. DoroszkoA. The human carbonic anhydrase ii in platelets: An underestimated field of its activity.Biomed. Res. Int.20182018454835310.1155/2018/4548353
     [Google Scholar]
  3. ShankR.P. DooseD.R. StreeterA.J. BialerM. Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase.Epilepsy Res.2005632-310311210.1016/j.eplepsyres.2005.01.00115715969
     [Google Scholar]
  4. ArslanO. Inhibition of bovine carbonic anhydrase by new sulfonamide compounds.Biochemistry (Mosc.)200166998298310.1023/A:101236542490011703179
     [Google Scholar]
  5. ShaikN.A. BokhariH.A. MasoodiT.A. ShettyP.J. AjabnoorG.M.A. ElangoR. BanaganapalliB. Molecular modelling and dynamics of CA2 missense mutations causative to carbonic anhydrase 2 deficiency syndrome.J. Biomol. Struct. Dyn.202038144067408010.1080/07391102.2019.167189931542996
     [Google Scholar]
  6. SupuranC.T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.Nat. Rev. Drug Discov.20087216818110.1038/nrd246718167490
     [Google Scholar]
  7. ZaraeiS.O. El-GamalM.I. ShafiqueZ. AmjadS.T. AfridiS. ZaibS. AnbarH.S. El-GamalR. IqbalJ. Sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as potent carbonic anhydrase II/IX/XII inhibitors.Bioorg. Med. Chem.201927173889390110.1016/j.bmc.2019.07.02631345748
     [Google Scholar]
  8. ParkkilaA.K. HervaR. ParkkilaS. RajaniemiH. Immunohistochemical demonstration of human carbonic anhydrase isoenzyme II in brain tumours.Histochem. J.1995271297498210.1007/BF023896878789398
     [Google Scholar]
  9. PastorekovaS. SupuranC.T. Hypoxia and Cancer, Biological Implications and Therapeutic Opportunities.Humana New York, NYSpringer2014
     [Google Scholar]
  10. ParkkilaS. RajaniemiH. ParkkilaA.K. KiveläJ. WaheedA. PastorekováS. PastorekJ. SlyW.S. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro.Proc. Natl. Acad. Sci. USA20009752220222410.1073/pnas.04055489710688890
     [Google Scholar]
  11. AchalV. PanX. Characterization of urease and carbonic anhydrase producing bacteria and their role in calcite precipitation.Curr. Microbiol.201162389490210.1007/s00284‑010‑9801‑421046391
     [Google Scholar]
  12. BozdagM. SupuranC.T. EspositoD. AngeliA. CartaF. MontiS.M. De SimoneG. AlterioV. 2-Mercaptobenzoxazoles: a class of carbonic anhydrase inhibitors with a novel binding mode to the enzyme active site.Chem. Commun. (Camb.)202056598297830010.1039/D0CC02857F32573627
     [Google Scholar]
  13. MiliteC. AmendolaG. NocentiniA. BuaS. CiprianoA. BarresiE. FeoliA. NovellinoE. Da SettimoF. SupuranC.T. CastellanoS. CosconatiS. TalianiS. Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies.J. Enzyme Inhib. Med. Chem.20193411697171010.1080/14756366.2019.166683631537132
     [Google Scholar]
  14. HouZ. LiC. LiuY. ZhangM. WangY. FanZ. GuoC. LinB. LiuY. Design, synthesis and biological evaluation of carbohydrate-based sulphonamide derivatives as topical antiglaucoma agents through selective inhibition of carbonic anhydrase II.J. Enzyme Inhib. Med. Chem.202035138339010.1080/14756366.2019.170529331865756
     [Google Scholar]
  15. PalaN. MichelettoL. SechiM. AggarwalM. CartaF. McKennaR. SupuranC.T. Carbonic anhydrase inhibition with benzenesulfonamides and tetrafluorobenzenesulfonamides obtained via click chemistry.ACS Med. Chem. Lett.20145892793010.1021/ml500196t25147616
     [Google Scholar]
  16. AkhtarW. KhanM.F. VermaG. ShaquiquzzamanM. RizviM.A. MehdiS.H. AkhterM. AlamM.M. Therapeutic evolution of benzimidazole derivatives in the last quinquennial period.Eur. J. Med. Chem.201712670575310.1016/j.ejmech.2016.12.01027951484
     [Google Scholar]
  17. KalininaT.S. ShimshirtA.A. VolkovaA.V. KorolevA.O. VoroninaT.A. Anxiolytic effects of diazepam and afobazole on the anxiety response evoked by GABA(A) receptor blockade in wistar rats and inbred mice of Balb/c and C57BI/6 strains.Eksp. Klin. Farmakol.201679103730085476
     [Google Scholar]
  18. BischofJ. LebanJ. ZajaM. GrotheyA. RadunskyB. OthersenO. StroblS. VittD. KnippschildU. 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε.Amino Acids20124341577159110.1007/s00726‑012‑1234‑x22331384
     [Google Scholar]
  19. RamurthyS. SubramanianS. AikawaM. AmiriP. CostalesA. DoveJ. FongS. JansenJ.M. LevineB. MaS. McBrideC.M. MichaelianJ. PickT. PoonD.J. GirishS. ShaferC.M. StuartD. SungL. RenhoweP.A. Design and synthesis of orally bioavailable benzimidazoles as Raf kinase inhibitors.J. Med. Chem.200851227049705210.1021/jm801050k18942827
     [Google Scholar]
  20. AliM. AliS. KhanM. RashidU. AhmadM. KhanA. Al-HarrasiA. UllahF. LatifA. Synthesis, biological activities, and molecular docking studies of 2-mercaptobenzimidazole based derivatives.Bioorg. Chem.20188047247910.1016/j.bioorg.2018.06.03229990895
     [Google Scholar]
  21. LatifA. BibiS. AliS. AmmaraA. AhmadM. KhanA. Al-HarrasiA. UllahF. AliM. New multitarget directed benzimidazole-2-thiol-based heterocycles as prospective anti-radical and anti-Alzheimer's agents.Drug Dev. Res.202182220721610.1002/ddr.2174032897587
     [Google Scholar]
  22. AgiliF. Novel hydrazide hydrazone derivatives as antimicrobial agents: Design, synthesis, and molecular dynamics.Processes (Basel)2024126105510.3390/pr12061055
     [Google Scholar]
  23. CuiP. LiuK. YangZ. SunP. MengY. YangQ. WuX. LvY. YangY. WuJ. Design, synthesis, and antiviral and fungicidal activities of 4-Oxo-4 H -quinolin-1-yl acylhydrazone derivatives.ACS Omega2024934acsomega.4c0504610.1021/acsomega.4c0504639220544
     [Google Scholar]
  24. ZongZ. ZhouF.Y. ChangQ. GaoF. LiuZ. FangS. ZhengX. TaoJ. LiangL. Four acylhydrazone based complexes: Inhibition of proliferation, inducing apoptosis and inhibiting cell migration.J. Mol. Struct.2024129513661710.1016/j.molstruc.2023.136617
     [Google Scholar]
  25. JoneidiS. AlizadehS.R. EbrahimzadehM.A. Chlorogenic acid derivatives: Structural modifications, drug design, and biological activities: A review.Mini Rev. Med. Chem.202424774876610.2174/138955752366623082209595937608658
     [Google Scholar]
  26. JiangS.L. HuZ.Y. SuiH.Y. HuangT. HanL. HuC.M. XuX.T. ShiJ.H. ChuC. Comprehending the inhibition mechanism of indole-based bis-acylhydrazone compounds on α-glucosidase: Spectral and theoretical approaches.Int. J. Biol. Macromol.2024276Pt 113348910.1016/j.ijbiomac.2024.13348938964679
     [Google Scholar]
  27. BoubekriY. SlassiS. AarjaneM. TaziB. AmineA. Microwave assisted synthesis, photoisomerization study and antioxidant activity of a series of N-acylhydrazones.Arab. J. Chem.202417910591310.1016/j.arabjc.2024.105913
     [Google Scholar]
  28. NaeemN. SadiqA. OthmanG.A. YassinH.M. MughalE.U. Exploring heterocyclic scaffolds in carbonic anhydrase inhibition: A decade of structural and therapeutic insights.RSC Advances20241448357693597010.1039/D4RA06290F39534850
     [Google Scholar]
  29. ShareefM.A. DeviG.P. Rani RouthuS. KumarC.G. KamalA. BabuB.N. New imidazo[2,1- b ]thiazole-based aryl hydrazones: Unravelling their synthesis and antiproliferative and apoptosis-inducing potential.RSC Med. Chem.202011101178118410.1039/D0MD00188K33479622
     [Google Scholar]
  30. MoiD. VittorioS. AngeliA. BalboniG. SupuranC.T. OnnisV. Investigation on hydrazonobenzenesulfonamides as human carbonic anhydrase I, II, IX and XII inhibitors.Molecules20222819110.3390/molecules2801009136615285
     [Google Scholar]
  31. BakhodaA. OkoromobaO.E. GreeneC. BoroujeniM.R. BertkeJ.A. WarrenT.H. Three-coordinate copper(ii) alkynyl complex in C–C bond formation: The sesquicentennial of the glaser coupling.J. Am. Chem. Soc.202014243184831849010.1021/jacs.0c0713732956589
     [Google Scholar]
  32. SapnaK. SharmaN.K. KohliS. Synthesis, characterization and antimicrobial studies of copper (II) complexes of semicarbazone and thiosemicarbazone of m-hydroxy benzaldehyde and p-hydroxy benzaldehyde.Orient. J. Chem.201228296997410.13005/ojc/280244
     [Google Scholar]
  33. XuX. WeiC. YangY. LiuM. LuoA. SongH. WangY. DuanX. New discovery of anti-ulcerative colitis active ingredients of Nostoc commune: p-Hydroxy benzaldehyde.J. Funct. Foods20217710432710.1016/j.jff.2020.104327
     [Google Scholar]
  34. LiX. FanR. XiangJ. YuanY. MaoX. ZhouN. P-hydroxy benzaldehyde facilitates reprogramming of reactive astrocytes into neurons via endogenous transcriptional regulation.Int. J. Neurosci.2023133101096110810.1080/00207454.2022.204977535321633
     [Google Scholar]
  35. MattaR. PochampallyJ. DhoddiB.N. BhookyaS. BitlaS. AkkirajuA.G. Synthesis, antimicrobial and antioxidant activity of triazole, pyrazole containing thiazole derivatives and molecular docking studies on COVID-19.BMC Chem.20231716110.1186/s13065‑023‑00965‑837330518
     [Google Scholar]
  36. KhanA. KhanM. HalimS.A. KhanZ.A. ShafiqZ. Al-HarrasiA. Quinazolinones as competitive inhibitors of carbonic anhydrase-II (human and bovine): Synthesis, in vitro, in silico, selectivity, and kinetics studies.Front. Chem.2020859809510.3389/fchem.2020.59809533335888
     [Google Scholar]
  37. RoseP.W. PrlićA. AltunkayaA. BiC. BradleyA.R. ChristieC.H. CostanzoL.D. DuarteJ.M. DuttaS. FengZ. The RCSB protein data bank: Integrative view of protein, gene and 3D structural information.Nucleic Acids Res.201645D1D271D28110.1093/nar/gkw1000
     [Google Scholar]
  38. SaitoR. SatoT. IkaiA. TanakaN. Structure of bovine carbonic anhydrase II at 1.95 Å resolution.Acta Crystallogr. D Biol. Crystallogr.200460479279510.1107/S090744490400316615039588
     [Google Scholar]
  39. LiuX. ShiD. ZhouS. LiuH. LiuH. YaoX. Molecular dynamics simulations and novel drug discovery.Expert Opin. Drug Discov.2018131233710.1080/17460441.2018.140341929139324
     [Google Scholar]
  40. CaseD.A. AktulgaH.M. BelfonK. CeruttiD.S. CisnerosG.A. CruzeiroV.W.D. ForouzeshN. GieseT.J. GötzA.W. GohlkeH. IzadiS. KasavajhalaK. KaymakM.C. KingE. KurtzmanT. LeeT.S. LiP. LiuJ. LuchkoT. LuoR. ManathungaM. MachadoM.R. NguyenH.M. O’HearnK.A. OnufrievA.V. PanF. PantanoS. QiR. RahnamounA. RishehA. Schott-VerdugoS. ShajanA. SwailsJ. WangJ. WeiH. WuX. WuY. ZhangS. ZhaoS. ZhuQ. CheathamT.E.III RoeD.R. RoitbergA. SimmerlingC. YorkD.M. NaganM.C. MerzK.M.Jr AmberTools.J. Chem. Inf. Model.202363206183619110.1021/acs.jcim.3c0115337805934
     [Google Scholar]
  41. TianC. KasavajhalaK. BelfonK.A.A. RaguetteL. HuangH. MiguesA.N. BickelJ. WangY. PincayJ. WuQ. SimmerlingC. ff19SB: Amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution.J. Chem. Theory Comput.202016152855210.1021/acs.jctc.9b0059131714766
     [Google Scholar]
  42. SenguptaA. LiZ. SongL.F. LiP. MerzK.M.Jr. Parameterization of monovalent ions for the OPC3, OPC, TIP3P-FB, and TIP4P-FB water models.J. Chem. Inf. Model.202161286988010.1021/acs.jcim.0c0139033538599
     [Google Scholar]
  43. WangB. MerzK.M. A fast QM/MM (quantum mechanical/molecular mechanical) approach to calculate nuclear magnetic resonance chemical shifts for macromolecules.J. Chem. Theory Comput.20062120921510.1021/ct050212s26626395
     [Google Scholar]
  44. WangJ. WangW. KollmanP.A. CaseD.A. Antechamber: An accessory software package for molecular mechanical calculations.J. Am. Chem. Soc.20012221
     [Google Scholar]
  45. KräutlerV. Van GunsterenW.F. HünenbergerP.H. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations.J. Comput. Chem.200122550150810.1002/1096‑987X(20010415)22:5<501::AID‑JCC1021>3.0.CO;2‑V
     [Google Scholar]
  46. HarrisJ.A. LiuR. Martins de OliveiraV. Vázquez-MontelongoE.A. HendersonJ.A. ShenJ. GPU-accelerated all-atom particle-mesh Ewald continuous constant pH molecular dynamics in Amber.J. Chem. Theory Comput.202218127510752710.1021/acs.jctc.2c0058636377980
     [Google Scholar]
  47. PressW.H. Numerical recipesCambridge University Press2007
     [Google Scholar]
  48. SindhikaraD.J. KimS. VoterA.F. RoitbergA.E. Bad seeds sprout perilous dynamics: Stochastic thermostat induced trajectory synchronization in biomolecules.J. Chem. Theory Comput.2009561624163110.1021/ct800573m26609854
     [Google Scholar]
  49. RoeD.R. CheathamT.E. III PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data.J. Chem. Theory Comput.2013973084309510.1021/ct400341p26583988
     [Google Scholar]
  50. KollmanP.A. MassovaI. ReyesC. KuhnB. HuoS. ChongL. LeeM. LeeT. DuanY. WangW. DoniniO. CieplakP. SrinivasanJ. CaseD.A. CheathamT.E. III Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models.Acc. Chem. Res.2000331288989710.1021/ar000033j11123888
     [Google Scholar]
  51. WangW. DoniniO. ReyesC.M. KollmanP.A. Biomolecular simulations: Recent developments in force fields, simulations of enzyme catalysis, protein-ligand, protein-protein, and protein-nucleic acid noncovalent interactions.Annu. Rev. Biophys. Biomol. Struct.200130121124310.1146/annurev.biophys.30.1.21111340059
     [Google Scholar]
  52. WangJ. HouT. XuX. Recent advances in free energy calculations with a combination of molecular mechanics and continuum models.Curr. Computeraided Drug Des.20062328730610.2174/157340906778226454
     [Google Scholar]
  53. OnufrievA. BashfordD. CaseD.A. Exploring protein native states and large-scale conformational changes with a modified generalized born model.Proteins200455238339410.1002/prot.2003315048829
     [Google Scholar]
  54. WeiserJ. ShenkinP.S. StillW.C. Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO).J. Comput. Chem.199920221723010.1002/(SICI)1096‑987X(19990130)20:2<217::AID‑JCC4>3.0.CO;2‑A
     [Google Scholar]
/content/journals/cmc/10.2174/0109298673365555250617114928
Loading
Imidazole-2-thione and Acylhydrazone Derivatives Targeting Carbonic Anhydrase-II: Synthesis, In Vitro Evaluations, and MM-GBSA Calculation
Curr. Med. Chem. 33, 939 (2026); https://doi.org/10.2174/0109298673365555250617114928
/content/journals/cmc/10.2174/0109298673365555250617114928
/content/journals/cmc/10.2174/0109298673365555250617114928
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): binding energy; carbonic anhydrase inhibitors; Carbonic anhydrase-II; glaucoma; molecular docking; molecular dynamics simulation

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test